911±¬ÁÏÍø

XClose

Global Business School for Health

Home
Menu

Research

Our work is at the forefront of elevating the impact of health and healthcare through exceptional leadership and strategic innovations.

UCL GBSH is a catalyst and global leader of business research for health. Research is organised across three themes: Management and Healthcare Innovation, Health Systems and Policy, and Health Economics, Finance, and Operations.ÌýÌý

Our evolving UCL GBSH research themes

Management and Healthcare Innovation (MHI)

MHI focuses on enhancing healthcare leadership, organisational performance, and overall population health and wellbeing through developing and testing theories on innovation, management, and organisations. MHI researchers bring these different theories to pressing issues in healthcare, including changing roles of healthcare professionals and organizations; new technologies and the need to refashion existing organizational structures, patterns of interaction, and institutional roles around these technologies; the rise of artificial intelligence and the digital transformation of healthcare; greater involvement of patients, families, and communities, in optimising healthcare; Ìýnew organisational models for private-public collaboration for health, and dynamics governing R&D supporting healthcare innovation.Ìý

Theme Lead: , Professor of Management and Healthcare Innovation

Health Systems and Policy (HSP)

HSP focuses on contextually relevant interdisciplinary research that generates insights and solutions for critical health systems and policy problems globally. Key questions of interest include (but are not limited to):

  • How can Primary Health Care be strengthened in changing contexts of rapid urbanisation, commercialisation, and ecological change? Ìý Ìý
  • How can the governance of mixed public-private health systems be improved to create public good and advance health equity?
  • How can a heterogeneous health workforce be effectively marshalled for the future needs of populations?
  • What opportunities and risks do the digital and information revolutions pose for health systems?Ìý
  • How can health systems be strengthened by institutionalising learning - through information, deliberation, and action?

The HSP research agenda is linked to action and impact through co-production and collaborative learning with health system stakeholders, policymakers, and citizens.

Theme lead: , Professor of Global Health Systems and Policy

Health Economics, Finance, and Operations

Leveraging the potency of economic analysis is indispensable in shaping effective health policy and practice. The application of economic evaluation and value-based healthcare approaches is key to achieving operational efficiencies in healthcare delivery. Efforts to enhance health and equity are advanced through behavioural and structural interventions. Additionally, exploring diverse models of healthcare financing and analysing the drivers of health spending contribute to informed decision-making, ensuring that resources are allocated in a way to achieve optimal health outcomes and societal well-being.Ìý

Theme lead: , Professor of Health Economics

Our Team

Research Faculty

, Professor of Management and Healthcare Innovation
, Professor of Global Health Systems and Policy
, Professor of Health Economics

, Assistant Professor in Health Informatics
, Assistant Professor in Health Economics
Dr Pratap Kumar,ÌýAssociate Professor in Digital Health PolicyÌý(joining autumn 2024)
Dr Rakesh Parashar,ÌýAssistant Professor in Health Systems and Policy
Dr Meike Schleiff,ÌýAssociate Professor in Health Systems and Policy (joining autumn 2024)
DrÌýShehla Zaidi, Associate Professor and Programme LeadÌýfor Global Healthcare Management
, Assistant Professor in Health Policy and Systems

Research Associates

Dr Angel Gonzalez de la Fuentes, Honorary Visiting Fellow
Dr Gupteswar Patel, Honorary Visiting Postdoctoral Fellow

Our Collaborators

Ìý

UCL: a global expert in health and 2nd in UK for research power

At 911±¬ÁÏÍø, health spans all of our faculty areas and approximately half of UCL’s staff are engaged in areas of global health and human wellbeing. We bring together the university's wealth of intellectual capital not only in biomedical science, but across material, life and social sciences, in engineering, maths, physics, law, education, the arts and so much more. This creates a powerful critical mass of expertise committed to excellence in research and innovation. At 911±¬ÁÏÍøe deliver real world impact through translational research which goes far beyond test tubes and microscopes.

UCL has come second in the UK for research powerÌýaccording to the Research Excellence Framework 2021 (REF). This was gauged by a measure of average research score multiplied by staff numbers submitted. For this, 93 per cent of our research was graded 4* ‘world leading’ and 3* ‘internationally excellent’.ÌýUCL is also ranked number 1Ìýfor research power in medicine, health and life sciences as well as social sciences.

Find out more about our recent REF rankings here.

Research with us

UCL's strategic partnerships

UCL cannot deliver global change alone thereforeÌýwe are more collaborative than any other major global health university. Our strategic partnerships bring together complementary strengths and deepen the impact of our cross disciplinary education and research. UCL has partnerships with industry, healthcare providers, non-governmental organisations (NGOs) and other centres of academic excellence across the world. We are a founding partner in one of the first academic health science partnerships, UCL Partners, working alongside 23 NHS hospital trusts, 20 clinical commissioning groups and nine other universities, to co-create healthcare solutions with access to a highly diverse patient population of over six million people registered at the partner hospitals.Ìý

Our research and partnership working also enriches global scholarship and delivers opportunities for a transformative education with a reputation for innovation, reach and legacy. We are committed to inclusivity and participation to reflect our global ambitions. The London School of Medicine for Women was established in 1874 and was the first medical school in Britain to train women as doctors, merging with UCL in 1998 to form a new school at 911±¬ÁÏÍø. Today, the Athena Swan accreditation for gender equality has been achieved across our broad scientific community at 911±¬ÁÏÍø.